T1	Outcomes 0 17	Long-term outcome
T2	Outcomes 246 291	predict the efficacy of antimigraine therapy.
T3	Outcomes 516 544	maintained treatment benefit
T4	Outcomes 554 561	benefit
T5	Outcomes 591 621	early onset migraine response.
